Carlsmed Affirms FY2026 Sales Guidance of $74.000M-$78.000M vs $74.830M Est

Benzinga Newsdesk www.benzinga.com Negative 66.5%

Neg 66.5% Neu 0% Pos 0%

Carlsmed (NASDAQ:CARL) affirms FY2026 sales outlook from $74.000 million-$78.000 million to $74.000 million-$78.000 million vs $74.830 million estimate.